SynthesisEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2025
Cost-effectiveness of an intraoperative antibacterial envelope in preventing cardiac implantable device-associated infections: a systematic review.
Synthesis in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsIntraoperative use of an antibacterial envelope during surgery for cardiac implantable electronic device (CIED) surgery reduces infection risk at increased procedural costs. The objective of this systematic review was to synthesize the published economic literature on the cost-effectiveness of the antibacterial envelope. METHODS AND
resultsA systematic review of the published literature was conducted to identify economic evaluations (i.e. cost-utility, cost-effectiveness, and cost-benefit studies) comparing the antibacterial envelope compared with standard of care in preventing post-operative CIED infection. Systematic review best practices were followed, and study quality was assessed. Of 142 unique citations, 7 studies met the inclusion criteria for qualitative synthesis. All cost-effectiveness studies were conducted from the healthcare payer perspective of high-income countries. The base case analysis of most economic studies (5/7) reported a cost per quality-adjusted life year gained that exceeded country-specific societal thresholds for good value in healthcare. Cost-effectiveness was highly dependent on the baseline infection risk. That is, at current pricing, the antibacterial envelope may be cost-effective at base infection rates of greater than 3%, and cost-savings at infection rates that exceed 6%.
conclusionRoutine use of an antibacterial envelope in patients undergoing CIED procedures (implantation or revision) is unlikely to be cost-effective except among those at high risk for post-operative infection. Individualized risk assessment may help guide efficient and value-based use of this technology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.